Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in COVID-19 Patients with Type 2 Diabetes
NCT04535700Phase 4Completed
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in coronavirus disease 2019 (COVID-19). Started Sep 2020; status: completed.
02
Drugs
pioglitazone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04535700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535700.